Patents by Inventor Teru Nakai

Teru Nakai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11890372
    Abstract: The present invention provides an infusion preparation that is inhibited from generation of unwanted insoluble matter after mixing of two liquids of the infusion preparation in long-term storage. More specifically, the present invention provides an infusion preparation comprising two chambers separated by a communicably openable partition, a first chamber containing a first-chamber infusion comprising a fat emulsion and further comprising at least one member selected from the group consisting of amino acids that have a buffer action, divalent organic acids, and trivalent organic acids, a second chamber containing a second-chamber infusion comprising an amino acid and at least calcium as an electrolyte, wherein a total concentration of the amino acids that have a buffer action, divalent organic acids, and trivalent organic acids in the first-chamber infusion is 0.15 to 0.5 g/L, and a mixture of the first- and second-chamber infusions has a pH of 6.
    Type: Grant
    Filed: March 13, 2019
    Date of Patent: February 6, 2024
    Assignee: OTSUKA PHARMACEUTICAL FACTORY, INC.
    Inventors: Seiji Tani, Seiji Fujita, Teru Nakai, Yasuhiro Kiuchi, Miyuki Yamanaka, Yui Hayashi, Hiroshi Kanno, Yu Saruwatari
  • Publication number: 20210007975
    Abstract: The present invention provides an infusion preparation that is inhibited from generation of unwanted insoluble matter after mixing of two liquids of the infusion preparation in long-term storage. More specifically, the present invention provides an infusion preparation comprising two chambers separated by a communicably openable partition, a first chamber containing a first-chamber infusion comprising a fat emulsion and further comprising at least one member selected from the group consisting of amino acids that have a buffer action, divalent organic acids, and trivalent organic acids, a second chamber containing a second-chamber infusion comprising an amino acid and at least calcium as an electrolyte, wherein a total concentration of the amino acids that have a buffer action, divalent organic acids, and trivalent organic acids in the first-chamber infusion is 0.15 to 0.5 g/L, and a mixture of the first- and second-chamber infusions has a pH of 6.
    Type: Application
    Filed: March 13, 2018
    Publication date: January 14, 2021
    Applicant: OTSUKA PHARMACEUTICAL FACTORY, INC.
    Inventors: Seiji TANI, Seiji FUJITA, Teru NAKAI, Yasuhiro KIUCHI, Miyuki YAMANAKA, Yui HAYASHI, Hiroshi KANNO, Yu SARUWATARI
  • Patent number: 6461633
    Abstract: The invention provides a reducing sugar-containing fat emulsion comprising an oil-in-water fat emulsion available upon emulsification of a fat with an emulsifier wherein a reducing sugar and at least one buffer substance selected from among organic acids with acid dissociation exponents in water within the range of 5.0-7.5 and their salts are concurrently contained in the water phase thereof, with the emulsion having been adjusted to pH 5.0-7.5; a reducing sugar-containing fat emulsion product which comprises a medicinal fluid containing a reducing sugar and a fat as sterilized with carbon dioxide gas dissolved therein and contained in a plastic infusion container, said plastic infusion container being accommodated together with a carbon dioxide gas absorber in a substantially oxygen-impermeable secondary container; and a method for their preparation and sterilization.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: October 8, 2002
    Assignee: Otsuka Pharmaceutical Factory, Inc.
    Inventors: Keiichi Kawakami, Katsushi Watanabe, Teru Nakai, Katsumi Uei, Aya Bandou, Tatsuya Ishii, Yuki Hirata, Takashi Fujimoto